TAK1-AMPK Pathway in Macrophages Regulates Hypothyroid Atherosclerosis.
Yunxiao YangYifan JiaYu NingWanwan WenYanwen QinHuina ZhangYunhui DuLinyi LiXiaolu JiaoYunyun YangGuanghui LiuMengling HuangMing ZhangPublished in: Cardiovascular drugs and therapy (2020)
Taken together, these data suggest that the accelerated AS in hypothyroid patients may be due to the suppression of TAK1-AMPK pathway in macrophages. This new finding may become a novel therapeutic target in hypothyroid AS.
Keyphrases